What should be the dose of insulin glargine (Lantus), insulin sensitivity factor (ISF), and insulin‑to‑carbohydrate ratio (ICR) for a 45‑year‑old man weighing 98.4 kg with newly diagnosed type 2 diabetes, hemoglobin A1c 14.5%, normal renal function, not in diabetic ketoacidosis, who received insulin drip rates of 2, 2, 3, 2, 2, 3, 3, 3, and 2 units over the past 8 hours?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Insulin Dosing Recommendations

Based on the patient's insulin drip history (averaging 2.4 units/hour over 8 hours, totaling approximately 19 units), I recommend starting Lantus at 20 units once daily, with an insulin sensitivity factor (ISF) of 1:50 mg/dL and an insulin-to-carbohydrate ratio (ICR) of 1:10 grams.

Rationale for Lantus Dose

The transition from IV insulin to subcutaneous basal insulin should be based on the average hourly infusion rate over the preceding 12 hours (or in this case, 8 hours available). The patient received an average of 2.4 units/hour, which extrapolates to approximately 58 units over 24 hours 1. However, this represents total insulin needs during acute hyperglycemia.

For transitioning to outpatient basal-bolus therapy in a newly diagnosed type 2 diabetes patient with severe hyperglycemia (A1c 14.5%), the Endocrine Society guidelines recommend:

  • Total daily dose (TDD) calculation: 0.5 units/kg/day for blood glucose in the 201-400 mg/dL range 2
  • For this 98.4 kg patient: 0.5 × 98.4 = 49 units TDD
  • Basal insulin component: 50% of TDD = approximately 25 units

However, given normal renal function (GFR >90) and the relatively modest IV insulin requirements (averaging only 2.4 units/hour), I recommend a more conservative starting dose of 20 units Lantus once daily 3. This accounts for:

  • The transition from acute hospital management to outpatient care
  • Reduced stress and improved oral intake
  • Prevention of hypoglycemia during the adjustment period

The FDA label for Lantus recommends starting at 10 units or 0.2 units/kg for insulin-naive type 2 diabetes patients 3. At 0.2 units/kg, this patient would receive approximately 20 units, which aligns with our recommendation.

Insulin Sensitivity Factor (ISF)

ISF = 1:50 mg/dL (meaning 1 unit of rapid-acting insulin will lower blood glucose by approximately 50 mg/dL)

Using the standard formula for ISF calculation 4:

  • 1800 ÷ TDD = 1800 ÷ 49 = approximately 1:37 mg/dL

However, for a newly diagnosed patient with severe insulin resistance (A1c 14.5%), I recommend starting more conservatively at 1:50 mg/dL to avoid hypoglycemia. This can be adjusted based on response. The correction scale from the Endocrine Society guidelines suggests using the "usual" column for most patients, which provides 4 units for glucose 141-180 mg/dL 2.

Insulin-to-Carbohydrate Ratio (ICR)

ICR = 1:10 grams (meaning 1 unit of rapid-acting insulin per 10 grams of carbohydrate)

Using the standard formula 4:

  • 500 ÷ TDD = 500 ÷ 49 = approximately 1:10 grams

This is an appropriate starting point for this insulin-resistant patient. Most patients start with 1:15 ratio, but given the severe hyperglycemia and likely significant insulin resistance, 1:10 is more appropriate 4.

Prandial Insulin Dosing

For the remaining 50% of TDD (approximately 25 units), divide into three equal doses before meals:

  • 8 units of rapid-acting insulin before each meal (breakfast, lunch, dinner)

Alternatively, the ADA guidelines suggest starting with 4 units per meal or 10% of basal dose per meal when A1c <8% 5. However, with this patient's A1c of 14.5%, starting with 8 units per meal is more appropriate, which can be adjusted based on pre-meal and 2-hour post-meal glucose readings.

Titration Strategy

Basal insulin titration 6, 7:

  • Increase by 2 units every 3 days if fasting glucose >110 mg/dL
  • Target fasting glucose: 80-130 mg/dL
  • If hypoglycemia (glucose <70 mg/dL) occurs, reduce dose by 10-20%

Prandial insulin adjustment 2:

  • If pre-meal glucose >110-140 mg/dL, increase the previous meal's insulin dose by 10-20%
  • If pre-meal glucose <70 mg/dL, decrease the previous meal's insulin dose by 10-20%

Critical Considerations

Common pitfalls to avoid:

  • Overbasalization: Do not continue escalating basal insulin beyond 0.5 units/kg/day (approximately 50 units for this patient) without reassessing the regimen 8
  • Insulin stacking: Ensure at least 4-6 hours between correction doses to avoid cumulative hypoglycemia 4
  • Failure to reduce basal when adding prandial: Some guidelines suggest reducing basal by 4 units or 10% when initiating prandial insulin to prevent hypoglycemia 5

For this patient specifically:

  • The relatively low IV insulin requirements (2.4 units/hour average) suggest he may not be as insulin-resistant as the A1c suggests, possibly indicating recent decompensation
  • Close glucose monitoring (at least 4 times daily: fasting and pre-meals) is essential during the first 2 weeks
  • Consider adding metformin if not contraindicated, as insulin is typically used with metformin 5
  • Glucagon prescription for emergency hypoglycemia treatment 6

Reassessment timeline:

  • Daily phone contact for first 3-5 days to review glucose logs and adjust doses
  • Office visit in 1-2 weeks for comprehensive review
  • A1c recheck in 3 months 6

Related Questions

What basal insulin glargine (Lantus) dose should be used for a patient receiving about 220 g/day of tube‑feed carbohydrates, currently on 68 units daily, with prednisone being tapered from 45 mg to 40 mg?
What is the equivalent dose of Lantus (insulin glargine) for a 36-year-old patient taking 10 units of Novolin (human insulin) per day?
What is the best approach to manage elevated fasting glucose levels in a patient with diabetes who is currently taking Lantus (insulin glargine)?
For a 45-year-old Hispanic male weighing 98.4 kg with newly diagnosed type 2 diabetes and normal renal function, currently on 30 U insulin glargine (Lantus) and an insulin-to-carbohydrate ratio of 1 U per 5 g carbohydrate, with post‑meal insulin drip rates of 6, 4, 8, 6 U and overnight fasting drip rates of 2 U each hour, what should the insulin-to-carbohydrate ratio, basal insulin glargine dose, and insulin sensitivity factor be?
For a 25‑year‑old woman at 28 weeks gestation with type 2 diabetes, weight 114 kg, on insulin glargine (Lantus) 32 U daily, insulin‑to‑carbohydrate ratio 1 U:5 g, and insulin sensitivity factor 1 U:25 mg/dL, who ate 55 g carbohydrate at 6 pm and had blood glucose 183 mg/dL at 9 pm and fasting glucose 187 mg/dL, how should her insulin sensitivity factor, insulin‑to‑carbohydrate ratio, and basal insulin dose be adjusted?
What is the definition of Ogilvie's syndrome and how should it be managed?
In a 4‑year post‑renal‑transplant patient on tacrolimus 2 mg twice daily and prednisolone 10 mg daily, currently intubated for active pulmonary tuberculosis, receiving intermittent haemodialysis, with CMV DNA ~15 500 IU/mL, normal liver function, thrombocytopenia, anemia, dengue IgM positivity, and no evidence of CMV organ disease, what is the severity of CMV infection, is antiviral therapy indicated, and what valganciclovir dose and treatment duration should be used?
What is the appropriate workup for abdominal pain in children?
What is the treatment goal of lurasidone, with ziprasidone as an adjunct, for a patient with oppositional defiant disorder, post‑traumatic stress disorder, depression, and an unspecified mood disorder?
What are the diagnostic tests for bacterial vaginosis?
Can you explain the imaging findings of my abdominal aorta showing an aneurysm with an endovascular stent, confirm whether there is any leak, and advise what further evaluation or management is needed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.